Liminatus Pharma (LIMN) Return on Equity (ROE) (2024 - 2026)

Liminatus Pharma (LIMN) Return on Equity (ROE) from Sep 30, 2024 to Mar 31, 2026. The TTM Liminatus Pharma (LIMN) Return on Equity (ROE) is 847.47%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.